Development of novel CH223191-based antagonists of the aryl hydrocarbon receptor

Pharmacology, Toxicology and Pharmaceutical Science

• Aromatic Hydrocarbon Receptor 100%
• Receptor Antagonist 20%
• 2,3,7,8-Tetrachlorodibenzodioxin 10%
• Carboxylate 10%
• Structure Activity Relationship 10%
• Xenobiotic Metabolism 10%
• Drug 10%
• Ligand 10%
• Electronegativity 10%
• Disease 10%
• Inflammation 10%
• Enzymes 10%
• Transcription Factors 10%
• Pathophysiology 10%
• Carboxamide 10%
• Pyrazole 10%

Neuroscience

• Aryl Hydrocarbon Receptor 100%
• Receptor Antagonist 20%
• In Vivo 10%
• Receptor Agonists 10%
• Transcription Factors 10%
• Receptor Modulation 10%
• Gene 10%
• Agonist 10%
• Cell Cycle Progression 10%
• Cell Fate 10%
• Enzyme Activity 10%
• Carboxylic Acid 10%
• Metabolic Pathway 10%
• Carboxamide 10%
• Pyrazole 10%